Literature DB >> 8998076

Cytomegalovirus modulates transcription factors necessary for the activation of the tumor necrosis factor-alpha promoter.

L J Geist1, H A Hopkins, L Y Dai, B He, M M Monick, G W Hunninghake.   

Abstract

Several studies have demonstrated that cytomegalovirus (CMV) infection increases expression of the tumor necrosis factor (TNF) gene. This effect is mediated, in part, by an effect of the CMV immediate early 1 (IE1) gene product on the TNF promoter. To further analyze these interactions, we used plasmids with TNF promoter truncations to determine the site within the promoter where the CMV IE1 gene product mediates its effect. The site was localized to a 40-base pair segment that contains a cAMP response element (CREB). Deletion of the cAMP response element increased basal promoter activation but had little effect on IE1-induced activation. Additional studies demonstrated that the cAMP element is flanked 5' by a PU.1 site and 3' by an NF-kappa B site, both of which increase expression of the TNF promoter. These sequences demonstrated IE1 responsiveness. We next determined the relevance of these observations for normal human cells by infecting human alveolar macrophages with CMV. In these studies we evaluated expression of NF-kappa B, PU.1 and CREB by gel shift assay at immediate early times after infection. We found that CMV infection increased the binding activity of NF-kappa B and PU.1 and decreased the binding activity of CREB. CMV infection also increased expression of the TNF gene in alveolar macrophages. These observations suggest that CMV increases TNF gene expression, in part, by altering the binding activity of transcription factors that regulate gene expression.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8998076     DOI: 10.1165/ajrcmb.16.1.8998076

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  9 in total

Review 1.  The role of the T cell in age-related inflammation.

Authors:  Richard Macaulay; Arne N Akbar; Sian M Henson
Journal:  Age (Dordr)       Date:  2012-01-15

2.  Hypoxia activates constitutive luciferase reporter constructs.

Authors:  Diane M Doran; Kashmira Kulkarni-Datar; David R Cool; Thomas L Brown
Journal:  Biochimie       Date:  2010-10-26       Impact factor: 4.079

3.  Modulation of the NFκb Signalling Pathway by Human Cytomegalovirus.

Authors:  Meaghan H Hancock; Jay A Nelson
Journal:  Virology (Hyderabad)       Date:  2017-07-31

4.  Cytomegalovirus IE2 protein stimulates interleukin 1beta gene transcription via tethering to Spi-1/PU.1.

Authors:  N Wara-aswapati; Z Yang; W R Waterman; Y Koyama; S Tetradis; B K Choy; A C Webb; P E Auron
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

Review 5.  Curcumin: an orally bioavailable blocker of TNF and other pro-inflammatory biomarkers.

Authors:  Bharat B Aggarwal; Subash C Gupta; Bokyung Sung
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

6.  Exogenous Nef is an inhibitor of Mycobacterium tuberculosis-induced tumor necrosis factor-alpha production and macrophage apoptosis.

Authors:  Kuldeep Kumawat; Sushil Kumar Pathak; Anna-Lena Spetz; Manikuntala Kundu; Joyoti Basu
Journal:  J Biol Chem       Date:  2010-01-12       Impact factor: 5.157

7.  Pulmonary cytomegalovirus reactivation causes pathology in immunocompetent mice.

Authors:  Charles H Cook; Yingxue Zhang; Daniel D Sedmak; Larry C Martin; Scott Jewell; Ronald M Ferguson
Journal:  Crit Care Med       Date:  2006-03       Impact factor: 7.598

8.  Human cytomegalovirus IE1 protein elicits a type II interferon-like host cell response that depends on activated STAT1 but not interferon-γ.

Authors:  Theresa Knoblach; Benedikt Grandel; Jana Seiler; Michael Nevels; Christina Paulus
Journal:  PLoS Pathog       Date:  2011-04-14       Impact factor: 6.823

9.  The human cytomegalovirus major immediate-early proteins as antagonists of intrinsic and innate antiviral host responses.

Authors:  Christina Paulus; Michael Nevels
Journal:  Viruses       Date:  2009-11-05       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.